Author:
Bocangel D,Zheng M,Mhashilkar A,Liu Y,Ramesh R,Hunt K K,Chada S
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Molecular Biology,Molecular Medicine
Reference39 articles.
1. Slamon DJ, Clark GM, Wong SJ, Levin WJ, Ullrich A, McGuire WL . Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235: 177–182.
2. Yu D, Hung MC . Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene 2000; 19: 6115–6121.
3. Baselga J, Norton L, Albaneli J, Young-Mee K, Mendelsohnm J . Recombinant humanized anti-Her2 antibody (Herceptin) enhances the anti-tumor activity of Paclitaxel and Doxorubicin against Her2/neu overexpressing human breast cancer xenografts. Cancer Res 1998; 58: 2825–2831.
4. Winer EP, Burstein HJ . New combinations with Herceptin in metastatic breast cancer. Oncology 2001; 61 (Suppl 2): 50–57.
5. Baselga J, Carbonell X, Castaneda-Soto NJ, Clemens M, Green M, Harvey V et al. Phase II study of efficacy, safety, and pharmacokinetics of trastuzumab monotherapy administered on a 3-weekly schedule. J Clin Oncol 2005; 23: 2162–2171.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献